Cleared Traditional

K210364 - Migraine Tens Digital Pain Reliever (FDA 510(k) Clearance)

Jun 2021
Decision
129d
Days
Class 2
Risk

K210364 is an FDA 510(k) clearance for the Migraine Tens Digital Pain Reliever. This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).

Submitted by Shenzhen Dongdixin Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on June 17, 2021, 129 days after receiving the submission on February 8, 2021.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..

Submission Details

510(k) Number K210364 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 2021
Decision Date June 17, 2021
Days to Decision 129 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PCC — Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.